Drug intelligence / Profile preview

japanese encephalitis vaccine (Boryung)

Development stage
Unknown
Lead developer
Boryung Biopharma
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Boryung Cell-culture Japanese Encephalitis Vaccine is an inactivated, Vero cell-derived vaccine developed by Boryung Biopharma for active immunization against Japanese encephalitis (JE). It is produced by cultivating the Beijing-1 strain of the Japanese encephalitis virus in Vero cells, followed by purification and inactivation with formaldehyde. This cell-culture method is designed to reduce the risk of adverse reactions associated with older mouse brain-derived vaccines. The vaccine is approved in South Korea for pediatric and adult populations and is administered via subcutaneous injection.

Brand names
Boryung Cell-culture Japanese Encephalitis Vaccine
Other names
Boryung Cell-culture Japanese Encephalitis Vaccine Inj.보령세포배양일본뇌염백신주
02

Targets

JEV prM/E (Japanese encephalitis virus prM/E antigen)

Beyond the preview

Go deeper on japanese encephalitis vaccine (Boryung).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on japanese encephalitis vaccine (Boryung).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call